PT-141 injections are a prescription treatment for low sexual desire in premenopausal women. Learn how they work, typical dosing, side effects, and safety.
PT-141 injections are a prescription form of bremelanotide, a drug the FDA approved in 2019 under the brand name Vyleesi for hypoactive sexual desire disorder (HSDD) in premenopausal women. It is given as a small subcutaneous shot into the abdomen or thigh, usually at least 45 minutes before anticipated sexual activity. PT-141 is not a hormone, a testosterone product, or an over-the-counter supplement, and it is not FDA-approved for men.
What PT-141 Is
Bremelanotide is a synthetic peptide modeled on alpha-melanocyte-stimulating hormone, a molecule the body produces naturally. Researchers first explored this peptide family for skin tanning, then noticed an unexpected effect: increased sexual interest among study participants.
That finding redirected the science toward sexual medicine. An intranasal version was studied first and later dropped from development because it raised blood pressure in trials, leaving the injectable as the version that reached the market.
- Drug class: melanocortin receptor agonist
- Route: subcutaneous injection, with intranasal use studied but unapproved
- Brand name in the US: Vyleesi
- Approved population: premenopausal women with acquired, generalized HSDD
How PT-141 Works in the Body
Bremelanotide binds melanocortin receptors, particularly MC4R, which cluster in brain regions linked to desire and reward. This is a central, brain-based mechanism rather than a blood-flow mechanism like PDE5 inhibitors such as sildenafil.
Because the drug acts on the nervous system, desire and arousal can shift without direct physical stimulation. Researchers think this difference explains why some people who do not respond to erectile dysfunction drugs still report effects from bremelanotide.
Dosing and Timing
The FDA-labeled dose is 1.75 mg injected subcutaneously, no more than once in 24 hours and no more than 8 doses per month. Many clinicians describe the standard pt-141 dosage as one fixed injection timed roughly 45 minutes before sexual activity.
Timing matters more than most people expect. Injecting too early or too late often means missing the window when the drug is most active.
| Form | Typical dose studied | Onset | Approval status (US) |
|---|---|---|---|
| Subcutaneous injection | 1.75 mg | About 45 minutes | FDA-approved for premenopausal women with HSDD |
| Nasal spray | 10 mg in early trials | Roughly 30 minutes | Not approved; development discontinued |
| Research-chemical vials | Unverified | Unknown | Not approved; labeled not for human use |
Dose ceilings exist because nausea and blood pressure changes become more likely with frequent use. Taking a larger dose has not been shown to improve results.
PT-141 for Men Compared With Women
The FDA approval covers premenopausal women only. Research on pt-141 for men with erectile dysfunction showed small improvements in some trials, but the data were not strong enough for regulators to approve it in that population.
Men who use bremelanotide generally do so off-label with a prescriber, or they purchase unregulated product online. Off-label prescribing by a licensed clinician is legal, but it is not the same as FDA approval, and it is not proof the drug works for that use.
Women who are postmenopausal, or whose low desire stems mainly from relationship stress or medication side effects, were not the focus of the approval trials. The drug may still help some of them, but the evidence is thinner.
How Long the Effects Last
Bremelanotide has a half-life of about 2.7 hours. A frequent question is how long does pt-141 last, and the honest answer is that it varies widely; many people report noticeable effects for a few hours, while others notice little at all.
Nausea usually peaks in the first hour and fades, and flushing can come and go. The desire-related effects typically fade well before the drug has fully cleared the body.
Side Effects and Safety Considerations
Nausea is the most common side effect, followed by flushing, headache, and injection site reactions. A smaller number of users develop darkening of the gums, skin, or nails with repeated use, a condition called hyperpigmentation that may not fully reverse.
Bremelanotide can temporarily raise blood pressure, so it is not appropriate for people with uncontrolled hypertension or known cardiovascular disease. It also slows gastric emptying, which can change how quickly oral medications are absorbed.
- Common: nausea, flushing, headache, injection site pain, fatigue
- Less common: hyperpigmentation, blood pressure spikes, vomiting
- Contraindications: cardiovascular disease, uncontrolled high blood pressure, pregnancy
- Worsened by: alcohol, which intensifies nausea
Anyone considering this medication should review heart health, current prescriptions, and pregnancy plans with a healthcare professional before injecting. Self-treating with unverified product removes the safety net of a clinician who can monitor blood pressure and side effects.
Legal Status and Buying Safely
In the United States, bremelanotide is a prescription-only medication and cannot legally be sold as a dietary supplement. People searching for where to buy pt-141 often land on research chemical websites that ship vials labeled "not for human use."
Those sellers market pt-141 injections as "research chemicals," yet the vials are not reviewed for purity, sterility, or actual peptide content. Independent testing of research peptides has repeatedly found underdosed, mislabeled, or contaminated products, which is a serious risk with any injectable.
Prescription access usually runs through a telehealth or in-person clinician, a specialty pharmacy, and prior authorization with insurance. Cash-pay pricing is an option when coverage is denied.
The Bottom Line
PT-141 is a legitimate FDA-approved injectable for a narrow group of women, not a general-purpose libido booster. Evidence in men is limited, unregulated online vials carry quality risk, and side effects such as nausea and blood pressure changes are common enough to matter.
Anyone weighing this option should start with a licensed prescriber rather than a website promising instant results.
Frequently Asked Questions
How long does a PT-141 injection take to work?
Effects usually begin within about 45 minutes to an hour after a subcutaneous injection. Bremelanotide has a half-life of roughly 2.7 hours, so the drug is largely cleared within a day. Many users report that the most noticeable effects fade within a few hours.
Is PT-141 FDA-approved for men?
No. Bremelanotide (Vyleesi) is FDA-approved only for premenopausal women with hypoactive sexual desire disorder. It was studied in men for erectile dysfunction and showed some benefit in trials, but regulators did not approve it for that use. Male use is therefore off-label.
What is the standard PT-141 dosage?
The FDA-labeled dose is 1.75 mg injected subcutaneously, no more than once every 24 hours and no more than 8 doses per month. Higher or more frequent doses have not been shown to work better and increase the risk of nausea and blood pressure changes. Doses sold on research chemical sites are not reliable.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.